Kennard William E 4

What Happened

• William E. Kennard, a director of MetLife, was issued/acquired 365 shares on March 10, 2026. The shares are valued at $70.60 each, for a total reported value of $25,769. This transaction is an award/acquisition (not an open-market purchase or sale) — the shares were credited as deferred shares under MetLife’s director compensation arrangements.

Key Details

• Transaction date and price: 2026-03-10 at $70.60 per share (365 shares; $25,769 total).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes: F1 indicates these are imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors (deferred shares represent stock payable but deferred). F2 explains shares held in trust for policyholders under the MetLife Policyholder Trust (general note in filing).
• Filing timeliness: Report filed 2026-03-12; this appears to be timely (Form 4 is typically due within two business days of the transaction).

Context

• These deferred-share credits are routine director compensation/dividend reinvestment events and do not represent an open-market purchase or sale. Such awards are standard and should be viewed as compensation mechanics rather than a direct market sentiment signal.